| P2093 | author name string | Snorri S Thorgeirsson | |
| | Eun Sung Park | |
| | Ju-Seog Lee | |
| | Yoon Jun Kim | |
| | Hyun Goo Woo | |
| | Yun-Han Lee | |
| | Tsuyoshi Ishikawa | |
| P2860 | cites work | Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis | Q24655006 |
| | Defining the role of mTOR in cancer | Q28235431 |
| | An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma | Q28237169 |
| | The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease | Q29547614 |
| | Open source clustering software | Q29547702 |
| | Coexpression analysis of human genes across many microarray data sets | Q30936126 |
| | A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. | Q31065517 |
| | Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors | Q34190883 |
| | Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors | Q34320113 |
| | Genetic regulators of large-scale transcriptional signatures in cancer | Q34537800 |
| | Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer | Q34560933 |
| | Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. | Q34710149 |
| | OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci | Q35179204 |
| | Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs | Q36494138 |
| | Focal gains of VEGFA and molecular classification of hepatocellular carcinoma | Q36984575 |
| | Pivotal role of mTOR signaling in hepatocellular carcinoma | Q37183244 |
| | The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. | Q40021818 |
| | Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth | Q40105523 |
| | Human scribble accumulates in colorectal neoplasia in association with an altered distribution of beta-catenin | Q40131614 |
| | Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth | Q40136518 |
| | Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia | Q40158237 |
| | Regional copy number-independent deregulation of transcription in cancer | Q40209266 |
| | Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells | Q40216291 |
| | Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators | Q40225712 |
| | Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance | Q40225720 |
| | Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis | Q41886998 |
| | Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma | Q41918713 |
| | Multiple regions within 8q24 independently affect risk for prostate cancer | Q42038345 |
| | Heat shock transcription factor (HSF1) plays a critical role in cell migration via maintaining MAP kinase signaling | Q42498513 |
| | Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma | Q44902374 |
| | mTOR and P70 S6 kinase expression in primary liver neoplasms | Q45205087 |
| | Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning | Q45728735 |
| | Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer | Q46520772 |
| | A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells | Q50115050 |
| | Systems biology and combination therapy in the quest for clinical efficacy. | Q51934858 |
| | Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. | Q52087746 |
| | High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients | Q57274902 |
| | Molecular pathogenesis of human hepatocellular carcinoma | Q74543031 |
| | Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma | Q80595806 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver carcinoma | Q18557387 |
| P304 | page(s) | 4059-4066 | |
| P577 | publication date | 2009-04-14 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Identification of potential driver genes in human liver carcinoma by genomewide screening | |
| P478 | volume | 69 | |